BAMCO Inc
RCKT icon

BAMCO Inc’s Rocket Pharmaceuticals RCKT Stock Holding History

BAMCO Inc’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75,000
Closed -$943K – 335
2024
Q4 		$943K Sell
75,000
-809,341
-92% -$12.2M ﹤0.01% 293
2024
Q3 		$16.3M Sell
884,341
-94,990
-10% -$1.95M 0.04% 220
2024
Q2 		$21.1M Sell
979,331
-11,213
-1% -$258K 0.06% 198
2024
Q1 		$26.7M Sell
990,544
-61,957
-6% -$1.76M 0.07% 187
2023
Q4 		$31.5M Sell
1,052,501
-55,516
-5% -$1.23M 0.08% 174
2023
Q3 		$22.7M Buy
1,108,017
+225,231
+26% +$4.09M 0.07% 184
2023
Q2 		$17.5M Buy
882,786
+35,900
+4% +$725K 0.05% 211
2023
Q1 		$14.5M Buy
846,886
+324,541
+62% +$6.35M 0.04% 214
2022
Q4 		$10.2M Buy
522,345
+502,345
+2,512% +$9.25M 0.03% 233
2022
Q3 		$319K Buy
+20,000
New +$312K ﹤0.01% 352

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc's RCKT Position: Q1 2025 in Review

BAMCO Inc sold out of Rocket Pharmaceuticals (RCKT) in Q1 2025, closing a stake of 75,000 shares — an estimated $943K sold.

BAMCO Inc first reported a position in RCKT in Q3 2022 and held it in 10 quarters. The position peaked at $31.5M in Q4 2023. 236 funds tracked by Wall St. Rank hold RCKT as of Q1 2025.

  • BAMCO Inc reported no remaining Rocket Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • BAMCO Inc sold 75,000 Rocket Pharmaceuticals shares in Q1 2025, an estimated $943K.
  • BAMCO Inc first reported a position in Rocket Pharmaceuticals in Q3 2022 and held it in 10 quarters.
  • BAMCO Inc's Rocket Pharmaceuticals position peaked at $31.5M in Q4 2023.
  • 236 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2025.

Based on BAMCO Inc's 13F filing for Q1 2025, filed 15 May 2025.